NivolumabHypophysitis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2037卷 / 1期

关键词：

D O I：

10.1007/s40278-024-72024-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：331 / 331

相关论文

共 50 条

[21] NivolumabHypophysitis leading to secondary adrenal insufficiency: case report
Reactions Weekly, 2021, 1877 (1) : 313 - 313
[22] NivolumabHypophysitis, hypothyroidism and central adrenal insufficiency: case report
Reactions Weekly, 2019, 1770 (1) : 306 - 306
[23] Ipilimumab/nivolumabHypophysitis, hypothyroidism and adrenal insufficiency: case report
Reactions Weekly, 2021, 1852 (1) : 247 - 247
[24] NivolumabHypophysitis, primary hypothyroidism and secondary adrenal insufficiency: case report
Reactions Weekly, 2018, 1714 (1) : 299 - 299
[25] Ipilimumab/nivolumabHypophysitis and Raynaud's-like phenomenon: case report
Reactions Weekly, 2020, 1816 (1) : 190 - 190
[26] Ipilimumab/levothyroxine sodium/nivolumabHypophysitis, adrenal insufficiency and syncopal episode: case report
Reactions Weekly, 2017, 1652 (1) : 159 - 159
[27] Ipilimumab/nivolumabHypophysitis and adrenal insufficiency following off label use: case report
Reactions Weekly, 2019, 1781 (1) : 207 - 207
[28] Ipilimumab/nivolumabHypophysitis and cerebral amyloid angiopathy-related inflammation: case report
Reactions Weekly, 2021, 1872 (1) : 267 - 267
[29] Ipilimumab/nivolumabHypophysitis: 5 case reports
Reactions Weekly, 2017, 1639 (1) : 169 - 169
[30] Ipilimumab/nivolumabHypophysitis: 3 case reports
Reactions Weekly, 2020, 1833 (1) : 216 - 216

← 1 2 3 4 5 →